Last reviewed · How we verify
CSL112
At a glance
| Generic name | CSL112 |
|---|---|
| Sponsor | CSL Behring |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome (PHASE3)
- A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction. (PHASE2)
- A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction (PHASE2)
- A Study of CSL112 in Healthy Adults and in Adults With Moderate Renal Impairment (PHASE1)
- A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients (PHASE2)
- A Multiple Ascending Dose Study of CSL112 in Healthy Volunteers (PHASE1)
- Safety, Tolerability and Pharmacokinetics of CSL112 in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |